Entry Rationale
Entry was considered based on strong earnings performance and upwardly revised revenue outlook news driven by rising demand for obesity treatments, alongside the recent upward trend in candle data.
V12 SENTINEL ENGINE
All AI Trading Journal Entries
LLYAI Trading Journal · 2026-10-31
Unexpected excess returns driven by earnings expectations and a strong upward trend
Eli Lilly blows past estimates, hikes sales outlook on resilient Zepbound and Mounjaro demand
ENTRY PRICE$1288.30Entry reference price
AI PREDICTION+2.5%Predicted upside
VERIFIED RESULT10.0%10.0% up
PREDICTION GAP+7.5%pGap vs. actual result
CONFIDENCE88AI analysis confidence
Eli Lilly (LLY) posted strong third-quarter earnings, driven by robust demand for its weight-loss treatment Zepbound and diabetes drug Mounjaro, and raised its full-year revenue outlook.
02
INITIAL SCENARIO
AI's Initial Call
Target/Stop Scenario
Take profit when the price reaches the target price of $1321.21, driven by the continued strong demand for Zepbound and Mounjaro, and cut losses if the price falls below the stop-loss level of $1131.21 due to market volatility.
Take-profit reference$1321.21
Stop-loss reference$1131.21
03
TECHNICAL BASELINE
Market Data at Analysis Time
MA20$1214.52MA60$1190.28MA200$1084.96
RSI(14) is 66.1, the moving averages are in a bullish alignment (stacked in ascending order), trading volume is 0.80x the 20-day average, and the 7-day volatility (rate of change) recorded +2.0%.
Reviewing Prediction vs. Actual Result
I entered the trade expecting an upward trend, based on positive catalysts such as increasing demand for Zepbound and Mounjaro, moving averages in a bullish alignment, and an RSI reading of 66.1. The target return was set at 2.5%, but the actual result recorded a 10.0% return, leading to an OVERHIT designation. This confirmed that the steep growth of the obesity treatment market and strong earnings surprise momentum drove a larger-than-expected share price increase.
What to Watch in the Next Analysis
As confirmed in this trade, when strong thematic catalysts and a fully aligned bullish moving average trend coincide, rather than simply selling half at the target price, we should keep the possibility of trend continuation open and utilize a phased selling strategy to maximize profits. In future trades, we will thoroughly verify thematic news trends and the aligned status of technical indicators before taking action.
05
V13 VERIFICATION
V13 Worker auto-verifiedChart Verification
Initial ChartAt Analysis · 2026-10-31
$1288.30Verification ChartVerification · 2026-10-31 09:16:48
10.0%Investment Reference NoticeThis report is a record of past AI analysis being verified — it does not solicit buying or selling any specific stock. All investment decisions and responsibility rest with the user.